Biopanning of polypeptides binding to bovine ephemeral fever virus G1 protein from phage display peptide library

BMC Veterinary Research

Volumn 14, Issue 1, 2018, Pages

  Hou, Peili ^a   Zhao, Guimin ^a   He, Chengqiang ^a   Wang, Hongmei ^a   He, Hongbin ^a  

^a SHANDONG NORMAL UNIVERSITY   (China)

Author keywords

Antiviral peptide; Bovine ephemeral fever virus; G1 binding peptide; Phage display random peptide library

Indexed keywords

GLYCOPROTEIN; POLYPEPTIDE; RESTRICTION ENDONUCLEASE; SYNTHETIC PEPTIDE; PEPTIDE; PROTEIN BINDING; VIRUS ANTIBODY;

AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; BIOPANNING; BOVINE EPHEMERAL FEVER VIRUS; CHEMILUMINESCENCE IMMUNOASSAY; CYTOPATHOGENIC EFFECT; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; IMMUNITY; IN VITRO STUDY; NONHUMAN; PEPTIDE LIBRARY; PLASMID; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; VIRAL PLAQUE ASSAY; VIRUS INFECTIVITY; VIRUS REPLICATION; WESTERN BLOTTING; ANIMAL; BACTERIOPHAGE; BOVINE; BOVINE EPHEMERAL FEVER; CELL LINE; GENETICS; METABOLISM; PHYSIOLOGY; VIROLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; BACTERIOPHAGES; CATTLE; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPHEMERAL FEVER; EPHEMERAL FEVER VIRUS, BOVINE; GLYCOPROTEINS; PEPTIDE LIBRARY; PEPTIDES; PROTEIN BINDING;

EID: 85042486176     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/s12917-017-1315-x     Document Type: Article

References (42)

1. St George TD. Bovine ephemeral fever: a review. Trop Anim Health Prod. 1988;20:194-202
2. Uren MF. Bovine ephemeral fever. Aust Vet J. 1989;66:233-6
3. Wang FI, Hsu AM, Huang KJ. Bovine ephemeral fever in Taiwan. J Vet Diagn Investig. 2001;13:462-7
4. Walker PJ. Bovine ephemeral fever in Australia and the world. Curr Top Microbiol Immunol. 2005;292:57-80
5. Walker PJ, Klement E. Epidemiology and control of bovine ephemeral fever. Vet Res. 2015;46:124
6. Yeruham I, Van Ham M, Bar D, Yadin H, Tiomkin D. Economic aspects of the 1999 outbreak of bovine ephemeral fever in dairy cattle herds in the Jordan Valley in Israel. Vet Rec. 2003;153:180-2
7. Nandi S, Negi BS. Bovine ephemeral fever: a review. Comp Immunol Microbiol Infect Dis. 1999;22:81-91
8. Walker PJ, Byrne KA, Cybinski DH, Doolan DL, Wang YH. Proteins of bovine ephemeral fever virus. J Gen Virol. 1991;72(Pt 1):67-74
9. Cybinski DH, Walker PJ, Byrne KA, Zakrzewski H. Mapping of antigenic sites on the bovine ephemeral fever virus glycoprotein using monoclonal antibodies. J Gen Virol. 1990;71(Pt 9):2065-72
10. Hertig C, Pye AD, Hyatt AD, Davis SS, McWilliam SM, Heine HG, Walker PJ, Boyle DB. Vaccinia virus-expressed bovine ephemeral fever virus G but not G(NS) glycoprotein induces neutralizing antibodies and protects against experimental infection. J Gen Virol. 1996;77(Pt 4):631-40
11. Kongsuwan K, Cybinski DH, Cooper J, Walker PJ. Location of neutralizing epitopes on the G protein of bovine ephemeral fever rhabdovirus. J Gen Virol. 1998;79(Pt 11):2573-81
12. Zheng FY, Lin GZ, Qiu CQ, Zhou JZ, Cao XA, Gong XW. Serological detection of bovine ephemeral fever virus using an indirect ELISA based on antigenic site G1 expressed in Pichia Pastoris. Vet J. 2010;185:211-5
13. Hsieh YC, Wang SY, Lee YF, Chen SH, Mak PO, Chu CY. DNA sequence analysis of glycoprotein G gene of bovine ephemeral fever virus and development of a double oil emulsion vaccine against bovine ephemeral fever. J Vet Med Sci. 2006;68:543-8
14. Zheng FY, Lin GZ, Qiu CQ. Expression, purification and antigenic characterization of the Epitope-G1 gene of bovine ephemeral fever virus in Escherichia Coli. Wei sheng wu xue bao. 2007;47:498-502
15. Ting LJ, Lee MS, Lee SH, Tsai HJ, Lee F. Relationships of bovine ephemeral fever epizootics to population immunity and virus variation. Vet Microbiol. 2014;173:241-8
16. Wang X, Zhong P, Luo PP, Wang KC. Antibody engineering using phage display with a coiled-coil heterodimeric fv antibody fragment. PLoS One. 2011;6:e19023
17. Frei JC, Lai JR. Protein and antibody engineering by phage display. Methods Enzymol. 2016;580:45-87
18. Odermatt A, Audige A, Frick C, Vogt B, Frey BM, Frey FJ, Mazzucchelli L. Identification of receptor ligands by screening phage-display peptide libraries ex vivo on microdissected kidney tubules. J Am Soc Nephrol. 2001; 12:308-16
19. Mohrluder J, Stangler T, Hoffmann Y, Wiesehan K, Mataruga A, Willbold D. Identification of calreticulin as a ligand of GABARAP by phage display screening of a peptide library. FEBS J. 2007;274:5543-55
20. Liu JK, Teng Q, Garrity-Moses M, Federici T, Tanase D, Imperiale MJ, Boulis NM. A novel peptide defined through phage display for therapeutic protein and vector neuronal targeting. Neurobiol Dis. 2005;19:407-18
21. Molek P, Strukelj B, Bratkovic T. Peptide phage display as a tool for drug discovery: targeting membrane receptors. Molecules. 2011;16:857-87
22. Wang X, Li G, Ren Y, Ren X. Phages bearing affinity peptides to bovine rotavirus differentiate the virus from other viruses. PLoS One. 2011;6:e28667
23. Wu J, Park JP, Dooley K, Cropek DM, West AC, Banta S. Rapid development of new protein biosensors utilizing peptides obtained via phage display. PLoS One. 2011;6:e24948
24. Toledo-Machado CM, Bueno LL, Menezes-Souza D, Machado-de-Avila RA, Nguyen C, Granier C, Bartholomeu DC, Chavez-Olortegui C, Fujiwara RT. Use of phage display technology in development of canine visceral leishmaniasis vaccine using synthetic peptide trapped in sphingomyelin/cholesterol liposomes. Parasit Vectors. 2015;8:133
25. Yin L, Luo Y, Liang B, Wang F, Du M, Petrenko VA, Qiu HJ, Liu A. Specific ligands for classical swine fever virus screened from landscape phage display library. Antivir Res. 2014;109:68-71
26. Zou H, Zarlenga DS, Sestak K, Suo S, Ren X. Transmissible gastroenteritis virus: identification of M protein-binding peptide ligands with antiviral and diagnostic potential. Antivir Res. 2013;99:383-90
27. Rajik M, Jahanshiri F, Omar AR, Ideris A, Hassan SS, YusoffK. Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2. Virol J. 2009;6:74
28. Chia SL, Tan WS, Shaari K, Abdul Rahman N, YusoffK, Satyanarayanajois SD. Structural analysis of peptides that interact with Newcastle disease virus. Peptides. 2006;27:1217-25
29. Welch BD, Francis JN, Redman JS, Paul S, Weinstock MT, Reeves JD, Lie YS, Whitby FG, Eckert DM, Hill CP, et al. Design of a potent D-peptide HIV-1 entry inhibitor with a strong barrier to resistance. J Virol. 2010;84:11235-44
30. Ho KL, YusoffK, Seow HF, Tan WS. Selection of high affinity ligands to hepatitis B core antigen from a phage-displayed cyclic peptide library. J Med Virol. 2003;69:27-32
31. He CQ, Liu YX, Wang HM, Hou PL, He HB, Ding NZ. New genetic mechanism, origin and population dynamic of bovine ephemeral fever virus. Vet Microbiol. 2016;182:50-6
32. Albertini AA, Baquero E, Ferlin A, Gaudin Y. Molecular and cellular aspects of rhabdovirus entry. Viruses. 2012;4:117-39
33. Zheng FY, Lin GZ, Qiu CQ, Zhou JZ, Cao XA, Gong XW. Development and application of G1-ELISA for detection of antibodies against bovine ephemeral fever virus. Res Vet Sci. 2009;87:211-2
34. Lim KS, Lee DY, Valencia GM, Won YW, Bull DA. Cell surface-engineering to embed targeting ligands or tracking agents on the cell membrane. Biochem Biophys Res Commun. 2017;482:1042-7
35. Ladner RC, Sato AK, Gorzelany J, de Souza M. Phage display-derived peptides as therapeutic alternatives to antibodies. Drug Discov Today. 2004;9(12):525-9
36. Hamzeh-Mivehroud M, Alizadeh AA, Morris MB, Church WB, Dastmalchi S. Phage display as a technology delivering on the promise of peptide drug discovery. Drug Discov Today. 2013;18:1144-57
37. Deshayes K, Schaffer ML, Skelton NJ, Nakamura GR, Kadkhodayan S, Sidhu SS. Rapid identification of small binding motifs with high-throughput phage display: discovery of peptidic antagonists of IGF-1 function. Chem Biol. 2002; 9:495-505
38. Belloc CG, Longhi SA, Pena C, Blank VA, Miranda ME, Retegui LA. Identification, synthesis and properties of a consensus peptide recognized by a monoclonal antibody directed to various type I cytokine receptors. Life Sci. 2007;81:553-9
39. de Souza CA, Teixeira PC, Faria RX, Krylova O, Pohl P, Alves LA. A consensus segment in the M2 domain of the hP2X(7) receptor shows ion channel activity in planar lipid bilayers and in biological membranes. Biochim Biophys Acta. 1818;2012:64-71
40. Wang C, Sun X, Suo S, Ren Y, Li X, Herrler G, Thiel V, Ren X. Phages bearing affinity peptides to severe acute respiratory syndromes-associated coronavirus differentiate this virus from other viruses. J Clin Virol. 2013;57: 305-10
41. Ren X, Liu B, Yin J, Zhang H, Li G. Phage displayed peptides recognizing porcine aminopeptidase N inhibit transmissible gastroenteritis coronavirus infection in vitro. Virology. 2011;410:299-306
42. Moghaddam E, Teoh B-T, Sam S-S, Lani R, Hassandarvish P, Chik Z, Yueh A, Abubakar S, Zandi K. Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Sci Rep. 2014;4:5452